FDA panel considers easing peptide restrictions

Advisers to the Food and Drug Administration are weighing the evidence for seven different peptides. Favorable votes would pave the way for easier access.

First seen 40m ago · latest update 40m ago · World · politics

Developing: this story surfaced recently from a single outlet. It appears early by design — expect the confidence score to move as more outlets report (or don’t).